Cargando…
Development and Validation of an HPLC–MS/MS Method for Pioglitazone from Nanocarriers Quantitation in Ex Vivo and In Vivo Ocular Tissues †
Pioglitazone (PGZ) is an oral anti-hyperglycemic agent, belongs to the class of thiazolidinediones, and is used for the treatment of diabetes mellitus type 2. In recent years, its anti-inflammatory activity has also been demonstrated in the literature for different diseases, including ocular inflamm...
Autores principales: | Miralles-Cardiel, Esther, Silva-Abreu, Marcelle, Calpena, Ana Cristina, Casals, Isidre |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8147631/ https://www.ncbi.nlm.nih.gov/pubmed/34063615 http://dx.doi.org/10.3390/pharmaceutics13050650 |
Ejemplares similares
-
Stabilization by Nano Spray Dryer of Pioglitazone Polymeric Nanosystems: Development, In Vivo, Ex Vivo and Synchrotron Analysis
por: Silva-Abreu, Marcelle, et al.
Publicado: (2021) -
Assessment of Efficacy and Safety Using PPAR-γ Agonist-Loaded Nanocarriers for Inflammatory Eye Diseases
por: Miralles, Esther, et al.
Publicado: (2022) -
Comparative Study of Ex Vivo Transmucosal Permeation of Pioglitazone Nanoparticles for the Treatment of Alzheimer’s Disease
por: Silva-Abreu, Marcelle, et al.
Publicado: (2018) -
Ex-Vivo and In-Vivo Assessment of Cyclamen europaeum Extract After Nasal Administration
por: Fernández-Campos, Francisco, et al.
Publicado: (2019) -
Quality by Design of Pranoprofen Loaded Nanostructured Lipid Carriers and Their Ex Vivo Evaluation in Different Mucosae and Ocular Tissues
por: Rincón, María, et al.
Publicado: (2022)